Pulmonary Hypertension of Newborn Clinical Trial
Official title:
Multicenter, Prospectively Defined Observational Registry With Retrospective Data Collection, Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide Via Invasive or Noninvasive Ventilation
Pulmonary hypertension is high blood pressure in the arteries to the lungs. It is a serious
condition. It causes the blood vessels that carry blood from the heart to the lungs to become
hard and narrow. When this happens, the heart has to work harder to pump the blood through.
Some babies are born with pulmonary hypertension (PH). Doctors might use INOmax (a gas the
baby breathes) to help newborn babies (neonates) with PH. This study will use information
from the records of registered babies to see how effective and safe INOmax is for treating
premature and other newborn babies for up to 11 days after they are born.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05703191 -
A Real-world Study of Nitric Oxide Generator and Delivery System
|
||
| Enrolling by invitation |
NCT04031508 -
Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH
|
Phase 2 | |
| Completed |
NCT05050045 -
Echocardiographic Screening of Healthy Neonates for Measuring Pulmonary Artery Pressure
|